 |
Phenylacetate |
|---|---|
| Trade Name | |
| Orphan Indication | For use as an adjunct to surgery, radiation therapy and chemotherapy for the treatment of patients with primary or recurrent malignant glioma |
| USA Market Approval | USA |
| USA Designation Date | 1998-03-06 00:00:00 |
| Sponsor | Elan Drug Delivery, Inc.;1300 Gould Dr.;Gainesville, Georgia, 30504 |
